Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.

Subjects

Subjects :

Docetaxel
Humans
Male
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Taxoids
Abiraterone Acetate
Prednisone

Details

Language :

English

ISSN :

1569-8041

Volume :

28

Issue :

3

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Report

Accession number :

28426121

Full Text :

https://doi.org/10.1093/annonc/mdw674